You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Reversal

Showing 26 - 50 of 2,039
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sugammadex, Motor Evoked Potentials Trial in Beijing (Sugammadex, Saline)

Completed
  • Sugammadex
  • Motor Evoked Potentials
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Sep 19, 2022

Depression Trial in Atlanta (Levodopa+carbidopa, Placebo)

Completed
Has Results
  • Depression
  • Atlanta, Georgia
    Emory University Hospital
Aug 24, 2022

Type 2 Diabetes Trial in Washington (plant-based diet)

Not yet recruiting
  • Type 2 Diabetes
  • plant-based diet
  • Washington, District of Columbia
    Physician Committee for Responsible Medicine
Oct 5, 2022

Ileostomy - Stoma Trial in Mardan (early feeding, conventional feeding)

Completed
  • Ileostomy - Stoma
  • early feeding
  • conventional feeding
  • Mardan, Kpk, Pakistan
    DHQ
Jan 13, 2023

Neostigmine, Neuromuscular Blocking Agents, Muscle Weakness Trial in Sorocaba (Reversal of moderate neuromuscular blockade,

Completed
  • Neostigmine
  • +2 more
  • Reversal of moderate neuromuscular blockade
  • +3 more
  • Sorocaba, SP, Brazil
    Santa Lucina Hospital
May 12, 2022

Colorectal Tumors, Diverticular Diseases, IBD Trial (Endoscopic restoration of gastrointestinal continuity after Hartmann

Not yet recruiting
  • Colorectal Neoplasms
  • +2 more
  • Endoscopic restoration of gastrointestinal continuity after Hartmann procedure
  • (no location specified)
Sep 24, 2023

Neuromuscular Blockade Trial in Atlanta (Sugammadex, Placebo)

Not yet recruiting
  • Neuromuscular Blockade
  • Atlanta, Georgia
    Grady Memorial Hospital
Dec 14, 2022

Magnesium Sulfate, Pregnancy; Pre-Eclampsia, Neuromuscular Blockade Trial in Eskisehir (pregnant women taking magnesium,

Recruiting
  • Magnesium Sulfate
  • +2 more
  • pregnant women taking magnesium
  • Placebo
  • Eskisehir, Turkey
    Eskisehir Osmangazi Universıty Faculty of Medicine
Sep 28, 2022

Diabetes Reversal and the Subgingival Microbiota

Recruiting
  • Diabetes type2
  • Bariatric Surgery Candidate
  • sample collection
  • Philadelphia, Pennsylvania
  • +1 more
Aug 12, 2022

Coagulation; Intravascular Trial in Miami (Protamine fixed dose, Protamine ratio dose)

Recruiting
  • Coagulation; Intravascular
  • Protamine fixed dose
  • Protamine ratio dose
  • Miami, Florida
  • +1 more
Jul 28, 2022

Healthy Trial in Groningen (Milvexian, 4-Factor Prothrombin Complex Concentrate (4F-PCC), Recombinant Human Factor VIIa

Recruiting
  • Healthy
  • Groningen, Netherlands
    PRA Health Sciences
Jan 3, 2023

Asthma Trial in Saskatoon (salbutamol aqueous solution, salbutamol pressurized metered dose inhaler, )

Not yet recruiting
  • Asthma
  • salbutamol aqueous solution
  • +2 more
  • Saskatoon, Saskatchewan, Canada
    Asthma Research Lab University of Saskatchewan Room 346 Ellis Ha
Jul 26, 2023

Type 2 Diabetes Trial in Montréal (Moderate-carbohydrate Mediterranean diet, Personalized exercice prescription and training,

Active, not recruiting
  • Type 2 Diabetes
  • Moderate-carbohydrate Mediterranean diet, Personalized exercice prescription and training, Intermittent fasting
  • Montréal, Quebec, Canada
    EPIC Center of the Montreal Heart Institute
Aug 8, 2022

Dysphonia, Spastic, Dysphonia, Laryngeal Dystonia Trial in Norfolk (Pyridostigmine Bromide 60 Milligrams (mg))

Recruiting
  • Dysphonia, Spastic
  • +2 more
  • Pyridostigmine Bromide 60 Milligrams (mg)
  • Norfolk, Virginia
    Eastern Virginia Medical School Ear, Nose, and Throat Surgeons
Jul 25, 2022

Postoperative Urinary Retention Trial in Charlotte (Sugammadex)

Recruiting
  • Postoperative Urinary Retention
  • Charlotte, North Carolina
    Carolinas Medical Center
Oct 28, 2022

Anesthesia, General, Neuromuscular Blockade Trial in Seoul (Sugammadex Injection 2mg/kg, Sugammadex Injection 4mg/kg, Sugammadex

Completed
Has Results
  • Anesthesia, General
  • Neuromuscular Blockade
  • Sugammadex Injection 2mg/kg
  • +3 more
  • Seoul, Jongro Gu, Korea, Republic of
    SNUH
Oct 20, 2022

Muscle Weakness Trial in Seattle (Protocol for rocuronium neuromuscular block)

Completed
Has Results
  • Muscle Weakness
  • Protocol for rocuronium neuromuscular block
  • Seattle, Washington
    University of Washington Medical Center
Oct 14, 2022

Shoulder Pain, Anesthesia Trial in Leuven (Deep neuromuscular block, Moderate neuromuscular block, Neuromuscular Blocking Agents

Recruiting
  • Shoulder Pain
  • Anesthesia
  • Deep neuromuscular block
  • +2 more
  • Leuven, Vlaams-Brabant, Belgium
    University Hospitals Leuven
Aug 9, 2022

Coagulation Disorder Trial (PROTHROMPLEX TOTAL, 4F-PCC)

Not yet recruiting
  • Coagulation Disorder
  • (no location specified)
Jul 14, 2022

Loop Ileostomy Trial in Stockholm, Södertälje (Mesh reinforcement, No reinforcement)

Recruiting
  • Loop Ileostomy
  • Mesh reinforcement
  • No reinforcement
  • Stockholm, Sweden
  • +2 more
Mar 30, 2022

Pharmacokinetics Trial in Guangzhou (Sugammadex)

Recruiting
  • Pharmacokinetics
  • Guangzhou, Guangdong, China
    Guangzhou Military Region General Hospital, Department of Anesth
Apr 13, 2022

Stoma Site Incisional Hernia Trial in Nanjing (Stoma reversal with bio-mesh placement)

Recruiting
  • Stoma Site Incisional Hernia
  • Stoma reversal with bio-mesh placement
  • Nanjing, Jiangsu, China
    Nanjing Drum Tower Hospital
Nov 16, 2022

Flumazenil Adverse Reaction, Ambulatory Surgery, Postoperative Nausea Trial in Seoul (Flumazenil)

Not yet recruiting
  • Flumazenil Adverse Reaction
  • +3 more
  • Seoul, Seoul-T'ǔkpyǒlshi, Korea, Republic of
    Konkuk University Medical Center
May 18, 2022

Intestinal Disease Trial in Orange (Neostigmine Injectable Solution, Sugammadex injection)

Not yet recruiting
  • Intestinal Disease
  • Neostigmine Injectable Solution
  • Sugammadex injection
  • Orange, California
    UC Irvine Medical Center
Oct 31, 2023

Burns Trial in Kansas City (Sugammadex, Neostigmine, Glycopyrrolate)

Recruiting
  • Burns
  • Kansas City, Kansas
    University of Kansas Medical Center
May 2, 2022